ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. The company was incorporated in 2021 and is headquartered in Vancouver, Canada.
Stock data | 2023 | Change |
---|---|---|
Shares Outstanding | 23.56M | -0.19% |
Employees | 0 | N/A |
Shareholder Equity | 523.39K | 44.37% |
Earnings | 2023 | Change |
---|---|---|
EPS | -0.2767 | N/A |